(ECPG) Encore Capital - Ratings and Ratios
Debt Recovery, Collection Services, Portfolio Management, Credit Management
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 33.3% |
| Value at Risk 5%th | 50.7% |
| Relative Tail Risk | -7.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | -7.78 |
| CAGR/Max DD | 0.04 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.330 |
| Beta | 1.471 |
| Beta Downside | 1.515 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.85% |
| Mean DD | 19.92% |
| Median DD | 18.44% |
Description: ECPG Encore Capital November 18, 2025
Encore Capital Group (NASDAQ:ECPG) is a specialty-finance firm that purchases defaulted consumer receivables at a discount, then manages those portfolios through collection, early-stage recovery, and credit-management services for both individual borrowers and credit-originators.
Key operational metrics from the most recent quarter (Q2 2024) show a net revenue of $332 million, a net interest margin of 7.4 %, and a portfolio recovery rate of roughly 28 % of face value-both the margin and recovery rate have trended upward as the company refines its data-analytics-driven collection platform.
The business is highly sensitive to macro-economic drivers: (1) U.S. consumer credit health, measured by delinquency rates and unemployment, directly influences the supply of distressed assets; (2) prevailing interest-rate levels affect the discount at which portfolios are bought and the cost of financing those purchases; and (3) regulatory scrutiny of debt-collection practices can impact operating costs and permissible collection tactics.
Given the cyclical nature of distressed-debt investing, analysts should monitor the Federal Reserve’s policy stance and the latest credit-card delinquency trends as leading indicators of future portfolio quality and pricing opportunities.
For a deeper dive into how these variables are modeled in practice, you might find ValueRay’s analytical toolkit useful for building a more granular outlook on ECPG’s valuation.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-45.1m TTM) > 0 and > 6% of Revenue (6% = 93.7m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 0.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -59.96% (prev 4.61%; Δ -64.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 159.9m > Net Income -45.1m (YES >=105%, WARN >=100%) |
| Net Debt (3.76b) to EBITDA (334.4m) ratio: 11.25 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (23.5m) change vs 12m ago -3.63% (target <= -2.0% for YES) |
| Gross Margin 60.96% (prev 51.02%; Δ 9.95pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 30.45% (prev 26.60%; Δ 3.86pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.05 (EBITDA TTM 334.4m / Interest Expense TTM 287.8m) >= 6 (WARN >= 3) |
Altman Z'' 0.13
| (A) -0.18 = (Total Current Assets 251.2m - Total Current Liabilities 1.19b) / Total Assets 5.26b |
| (B) 0.21 = Retained Earnings (Balance) 1.08b / Total Assets 5.26b |
| (C) 0.06 = EBIT TTM 303.6m / Avg Total Assets 5.13b |
| (D) 0.22 = Book Value of Equity 952.9m / Total Liabilities 4.31b |
| Total Rating: 0.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.22
| 1. Piotroski 4.0pt |
| 2. FCF Yield 2.61% |
| 3. FCF Margin 8.45% |
| 4. Debt/Equity 4.13 |
| 5. Debt/Ebitda 11.25 |
| 6. ROIC - WACC (= 1.00)% |
| 7. RoE -5.25% |
| 8. Rev. Trend 19.67% |
| 9. EPS Trend -8.29% |
What is the price of ECPG shares?
Over the past week, the price has changed by +1.56%, over one month by +4.20%, over three months by +37.95% and over the past year by +17.31%.
Is ECPG a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ECPG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60.3 | 7.5% |
| Analysts Target Price | 60.3 | 7.5% |
| ValueRay Target Price | 62.4 | 11.4% |
ECPG Fundamental Data Overview January 04, 2026
P/E Forward = 5.5432
P/S = 0.8243
P/B = 1.2721
P/EG = 0.1692
Beta = 1.482
Revenue TTM = 1.56b USD
EBIT TTM = 303.6m USD
EBITDA TTM = 334.4m USD
Long Term Debt = 3.01b USD (from longTermDebt, last quarter)
Short Term Debt = 927.2m USD (from shortTermDebt, last quarter)
Debt = 3.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.76b USD (from netDebt column, last quarter)
Enterprise Value = 5.05b USD (1.29b + Debt 3.93b - CCE 172.5m)
Interest Coverage Ratio = 1.05 (Ebit TTM 303.6m / Interest Expense TTM 287.8m)
FCF Yield = 2.61% (FCF TTM 131.8m / Enterprise Value 5.05b)
FCF Margin = 8.45% (FCF TTM 131.8m / Revenue TTM 1.56b)
Net Margin = -2.89% (Net Income TTM -45.1m / Revenue TTM 1.56b)
Gross Margin = 60.96% ((Revenue TTM 1.56b - Cost of Revenue TTM 609.3m) / Revenue TTM)
Gross Margin QoQ = 55.75% (prev 73.37%)
Tobins Q-Ratio = 0.96 (Enterprise Value 5.05b / Total Assets 5.26b)
Interest Expense / Debt = 1.79% (Interest Expense 70.5m / Debt 3.93b)
Taxrate = 25.24% (25.2m / 99.9m)
NOPAT = 227.0m (EBIT 303.6m * (1 - 25.24%))
Current Ratio = 0.21 (Total Current Assets 251.2m / Total Current Liabilities 1.19b)
Debt / Equity = 4.13 (Debt 3.93b / totalStockholderEquity, last quarter 952.9m)
Debt / EBITDA = 11.25 (Net Debt 3.76b / EBITDA 334.4m)
Debt / FCF = 28.53 (Net Debt 3.76b / FCF TTM 131.8m)
Total Stockholder Equity = 858.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.86% (Net Income -45.1m / Total Assets 5.26b)
RoE = -5.25% (Net Income TTM -45.1m / Total Stockholder Equity 858.8m)
RoCE = 7.86% (EBIT 303.6m / Capital Employed (Equity 858.8m + L.T.Debt 3.01b))
RoIC = 4.83% (NOPAT 227.0m / Invested Capital 4.70b)
WACC = 3.83% (E(1.29b)/V(5.22b) * Re(11.44%) + D(3.93b)/V(5.22b) * Rd(1.79%) * (1-Tc(0.25)))
Discount Rate = 11.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.47%
[DCF Debug] Terminal Value 62.02% ; FCFE base≈124.7m ; Y1≈99.9m ; Y5≈68.1m
Fair Price DCF = 34.95 (DCF Value 779.5m / Shares Outstanding 22.3m; 5y FCF grow -23.79% → 3.0% )
EPS Correlation: -8.29 | EPS CAGR: -21.31% | SUE: -0.93 | # QB: 0
Revenue Correlation: 19.67 | Revenue CAGR: 6.99% | SUE: 0.89 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.79 | Chg30d=+0.050 | Revisions Net=+2 | Analysts=2
EPS next Year (2026-12-31): EPS=8.09 | Chg30d=+0.385 | Revisions Net=+2 | Growth EPS=-13.9% | Growth Revenue=+2.6%
Additional Sources for ECPG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle